Management of Extraglandular Manifestations of Primary Sjogren's Syndrome

被引:5
|
作者
Wu, Jason J. [1 ,2 ]
Carsons, Steven E. [1 ,3 ]
机构
[1] Winthrop Univ Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Mineola, NY 11501 USA
[2] Nassau Cty Med Ctr, E Meadow, NY 11554 USA
[3] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA
关键词
Sjogren's syndrome; Joint pain; NSAIDs; Anti-TNF; POLYUNSATURATED FATTY-ACIDS; DOUBLE-BLIND; CLINICAL-SIGNIFICANCE; RHEUMATOID-ARTHRITIS; FATIGUE; INVOLVEMENT; RITUXIMAB; VASCULITIS; EFFICACY;
D O I
10.1016/j.coms.2013.09.009
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Primary Sjogren's syndrome can have multiple extra-glandular manifestations ranging from mild to severe. Treatment for extra-glandular manifestations is organ specific and therapies are targeted based on the primary organs involved. Preferred treatment options used for extra-glandular manifestations of Sjogren's syndrome are usually extrapolated from the physician's experience in treating similar manifestations in other autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematous. The lack of immunomodulating disease modifying drugs in Sjogren's syndrome can be frustrating for patients dealing with extra-glandular manifestations, however recent advances in the field has made the future look promising for new therapeutic options.
引用
收藏
页码:101 / +
页数:10
相关论文
共 50 条
  • [41] B-cell depletion with rituximab in the treatment of primary Sjogren's syndrome: what have we learnt?
    Grigoriadou, S.
    Chowdhury, F.
    Pontarini, E.
    Tappuni, A.
    Bowman, S. J.
    Bombardieri, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : S217 - S224
  • [42] Criteria sets for primary Sjogren’s syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features
    Yasemin Kabasakal
    Gul Kitapçıoğlu
    Gonca Karabulut
    Mehmet Tezcan
    Ayse Balkarlı
    Adem Aksoy
    Şule Yavuz
    Sema Yılmaz
    Timuçin Kaşifoğlu
    Umut Kalyoncu
    Ediz Dalkılıç
    Abdurrahman Tufan
    Rıdvan Mercan
    Fatih Yıldız
    Taşkın Şentürk
    Fatoş Önen
    Cemal Bes
    Eren Erken
    Ercan Tunç
    Sevil Kamalı
    Emine Tarhan
    Ayten Yazıcı
    Nurşen Düzgün
    Müge Bıçakçıgil
    Sedat Yılmaz
    Mustafa Özmen
    Lale Öcal
    Fatma Alibaz-Öner
    Dilek Solmaz
    Veli Çobankara
    Selim Nalbant
    Esen Kasapoğlu Günal
    Derya Kaşkari
    Berna Göker
    Rheumatology International, 2017, 37 : 675 - 684
  • [43] Anti-CD20 Antibody in Primary Sjogren's Syndrome Management
    Chen, Shiju
    Liu, Yuan
    Shi, Guixiu
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2014, 15 (06) : 535 - 541
  • [44] Management of primary Sjogren's syndrome: recent developments and new classification criteria
    Del Papa, Nicoletta
    Vitali, Claudio
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (02) : 39 - 54
  • [45] Criteria sets for primary Sjogren's syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features
    Kabasakal, Yasemin
    Kitapcioglu, Gul
    Karabulut, Gonca
    Tezcan, Mehmet
    Balkarli, Ayse
    Aksoy, Adem
    Yavuz, Aule
    Yilmaz, Sema
    Kasifoglu, Timucin
    Kalyoncu, Umut
    Dalkilic, Ediz
    Tufan, Abdurrahman
    Mercan, Ridvan
    Yildiz, Fatih
    Senturk, Taskin
    Onen, Fatos
    Bes, Cemal
    Erken, Eren
    Tunc, Ercan
    Kamali, Sevil
    Tarhan, Emine
    Yazici, Ayten
    Duzgun, Nursen
    Bicakcigil, Muge
    Yilmaz, Sedat
    Ozmen, Mustafa
    Ocal, Lale
    Alibaz-Oner, Fatma
    Solmaz, Dilek
    Cobankara, Veli
    Nalbant, Selim
    Gunal, Esen Kasapoglu
    Kaskari, Derya
    Goker, Berna
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (05) : 675 - 684
  • [46] Eligibility for clinical trials in primary Sjogren's syndrome: lessons from the UK Primary Sjogren's Syndrome Registry
    Oni, Clare
    Mitchell, Sheryl
    James, Katherine
    Ng, Wan-Fai
    Griffiths, Bridget
    Hindmarsh, Victoria
    Prices, Elizabeth
    Pease, Colin T.
    Emery, Paul
    Lanyon, Peter
    Jones, Adrian
    Bombardieri, Michele
    Sutcliffe, Nurhan
    Pitzalis, Costantino
    Hunter, John
    Gupta, Monica
    McLaren, John
    Cooper, Annie
    Regan, Marian
    Giles, Ian
    Isenberg, David
    Saravanan, Vadivelu
    Coady, David
    Dasgupta, Bhaskar
    McHugh, Neil
    Young-Min, Steven
    Moots, Robert
    Gendi, Nagui
    Akil, Mohammed
    Barone, Francesca
    Fisher, Ben
    Rauz, Saaeha
    Richards, Andrea
    Bowman, Simon J.
    RHEUMATOLOGY, 2016, 55 (03) : 544 - 552
  • [47] The effects of resistance training in patients with primary Sjogren's syndrome
    Dardin, Luciana Paula
    Andreo Garcia, Ana Beatriz
    Minali, Paulo Alexandre
    Pereira Nunes Pinto, Ana Carolina
    Moca Trevisani, Virginia Fertnandes
    CLINICAL RHEUMATOLOGY, 2022, 41 (04) : 1145 - 1152
  • [48] Primary Sjogren's syndrome: Pathophysiological, clinical and therapeutic advances
    Gottenberg, J. -E.
    JOINT BONE SPINE, 2009, 76 (06) : 591 - 594
  • [49] Granulomatous interstitial nephritis associated with Primary Sjogren's syndrome
    Bitik, B.
    Gonul, I. I.
    Haznedaroglu, S.
    Goker, B.
    Tufan, A.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 (05): : 458 - 460
  • [50] Primary Sjogren's syndrome: too dry and too tired
    Ng, Wan-Fai
    Bowman, Simon J.
    RHEUMATOLOGY, 2010, 49 (05) : 844 - 853